Our group mainly focuses on understanding transcriptional and epigenetic mechanisms underlying chronic inflammatory skin diseases. 

We have knowledge and experimental expertise in immunology and molecular biology of stromal cells in skin tissues. 

We established and maintained multiple interdisciplinary collaborations with key researchers in the field and presented core findings at international conferences. 

Verify New Efficacy and Mechanism Study of Natural Compounds

Study of Drug and Transcriptomic Interactions

Recent Publications

Lee, H., Jang, H., Kim, J., Maeng, S., & Kim, J. (2025). Bladder Cancer Medication Bacillus Calmette‑Guérin‑Cell Wall Skeleton Focusing on Alternatives and Developments to Limitations. J Cancer Prev, 30(1), 1–6. https://doi.org/10.15430/JCP.25.002. 

Kim, J. (2025). Chronic inflammatory skin disorders: understanding pathophysiology and therapeutic challenges. J Appl Biol Chem, 68:8, 50‒55. https://doi.org/10.3839/jabc.2025.008

Kim, J. & Detmar, M. (2024). Stromal cells and epigenetics: emerging key players of chronic inflammatory skin diseases. BMB Rep, 57(11):465–471. https://doi.org/10.5483/BMBRep.2024-0039.

Kim, J., He, Y., Tormen, S., Kleindienst, P., Ducoli, L., Restivo, G., Drach, M., Levesque, P.M., Navarini, A.A., Tacconi, C., Detmar, M. (2023). The p300/CBP inhibitor A485 normalizes psoriatic fibroblast gene expression in vitro and reduces psoriasis-like skin inflammation in vivo. J Invest Dermatol, S0022- 202X(22)01937-6. 

He, Y., Kim, J., Tacconi, C., Moody, J., Dieterich, L.C., Anzengruber, F., Maul, J.T., Gousopoulos, E., Restivo, G., Levesque, M.P., Lindenblatt, N., Shin, J.W., Hon, C.C., Detmar, M. (2022). Mediators of capillary-to-venule conversion in the chronic inflammatory skin disease psoriasis. J Invest Dermatol, S0022-202X(22)01542-1 

He, Y., Tacconi, C., Dieterich, L.C., Kim, J., Restivo, G., Gousopoulos, E., Lindenblatt, N., Levesque, M.P., Claassen, M., Detmar, M. (2022). Novel blood vascular endothelial subtype-specific markers in human skin unearthed by single-cell transcriptomic profiling. Cells, 11(7): 1111. 

Ducoli, L., Agrawal, S., Sibler, E., Kouno, T., Tacconi, C., Hon, C.-C., Berger, S.D., Müllhaupt, D., He, Y., Kim, J., D’Addio, M., Dieterich, L.C., Carninci, P., Hoon, M.J.L. de, Shin, J.W., Detmar, M. (2021). LETR1 is a lymphatic endothelial-specific lncRNA governing cell proliferation and migration through KLF4 and SEMA3C. Nat Commun 12, 925.